|国家科技期刊平台
首页|期刊导航|临床医学工程|布地奈德雾化吸入联合高频振荡通气治疗新生儿呼吸窘迫综合征的效果观察

布地奈德雾化吸入联合高频振荡通气治疗新生儿呼吸窘迫综合征的效果观察OA

Observation on the Effect of Budesonide Atomization Inhalation Combined with High Frequency Oscillatory Ventilation in the Treatment of Neonatal Respiratory Distress Syndrome

中文摘要英文摘要

目的 观察布地奈德雾化吸入联合高频振荡通气(HFOV)治疗新生儿呼吸窘迫综合征(NRDS)的效果和安全性.方法 68例NRDS患儿随机分为两组各34例.在常规治疗基础上,对照组采用布地奈德混悬液雾化吸入治疗,观察组采用布地奈德混悬液雾化吸入+HFOV治疗.比较两组的恢复情况、血气指标及并发症.结果 观察组的通气、氧疗及住院时间均短于对照组,治疗期间的并发症总发生率低于对照组(P<0.05).治疗1周后,观察组的PaO2、pH值均高于对照组,PaCO2低于对照组(P<0.05).结论 布地奈德雾化吸入联合HFOV治疗可有效调节NRDS患儿的血气指标,减少并发症的发生,加快患儿康复.

Objective To observe the effect and safety of budesonide atomization inhalation combined with high frequency oscillatory ventilation(HFOV)in the treatment of neonatal respiratory distress syndrome(NRDS).Methods A total of 68 neonates with NRDS were randomly divided into two groups,with 34 cases in each group.On the basis of conventional treatment,the control group was treated with budesonide suspension atomization inhalation,and the observation group was treated with budesonide suspension atomization inhalation+HFOV.The recovery situation,blood gas indicators and complications were compared between the two groups.Results The ventilation time,oxygen therapy time and hospitalization time of the observation group were shorter than those of the control group,and the total incidence of complications during treatment was lower than that of the control group(P<0.05).After 1 week of treatment,PaO2 and pH value of the observation group were higher than those of the control group,and PaCO2 was lower than that of the control group(P<0.05).Conclusions Budesonide atomization inhalation combined with HFOV treatment can effectively regulate the blood gas indicators of neonates with NRDS,reduce the occurrence of complications,and accelerate the recovery of neonates.

梁惠如;彭二扣;宋瑞

商丘市第一人民医院新生儿重症监护室,河南商丘 476000商丘市第一人民医院儿童重症监护室,河南商丘 476000

临床医学

布地奈德雾化吸入高频振荡通气新生儿呼吸窘迫综合征

Budesonide atomization inhalationHigh frequency oscillatory ventilationNeonatal respiratory distress syndrome

《临床医学工程》 2024 (010)

1171-1172 / 2

10.3969/j.issn.1674-4659.2024.10.1171

评论